Orbifloxacin
From Wikipedia, the free encyclopedia
| This article does not cite any references or sources. (May 2008) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
|
Orbifloxacin
|
|
| Systematic (IUPAC) name | |
| 1-Cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C19H20F3N3O3 |
| Mol. mass | 395.37 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
veterinary use only |
| Routes | Oral |
Orbifloxacin (brand name Orbax) is a is a fluoroquinolone antibiotic which is approved for use in dogs, marketed by Schering-Plough Animal Health.
|
|||||||||||

